Ketamine hcl and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Ketamine hcl (ketamine hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Gabapentin, and have Crohn's disease.

The phase IV clinical study analyzes which people have Weakness when taking Ketamine hcl. It is created by eHealthMe based on reports of 1,742 people who have side effects when taking Ketamine hcl from the FDA, and is updated regularly.

What is Ketamine hcl?

Ketamine hcl has active ingredients of ketamine hydrochloride. It is often used in pain. eHealthMe is studying from 1,851 Ketamine hcl users. Check the latest studies of Ketamine hcl.

What is Weakness?

Weakness is found to be associated with 3,638 drugs and 6,618 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

1,742 people reported to have side effects when taking Ketamine hcl.
Among them, 30 people (1.72%) have Weakness.

Among these 30 people:

How long have people been on Ketamine hcl when they have Weakness? *

What is the gender of people who have Weakness when taking Ketamine hcl? *

female: 60 %
male: 40 %

What is the age of people who have Weakness when taking Ketamine hcl? *

What are other drugs people take besides Ketamine hcl? *

What are other side effects people have besides Weakness? *

Vision Blurred: 9 people, 30.00%
Fatigue (feeling of tiredness): 8 people, 26.67%
Gait Disturbance: 7 people, 23.33%
Mobility Decreased (ability to move is reduced): 6 people, 20.00%
Visual Acuity Reduced (reduced clearness of vision): 6 people, 20.00%
Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function): 6 people, 20.00%
Joint Pain: 6 people, 20.00%
Fever: 6 people, 20.00%
Areflexia (absence of a reflex): 6 people, 20.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 6 people, 20.00%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 6 people, 20.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 6 people, 20.00%
Breast Cancer: 4 people, 13.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 13.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 10.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 10.00%
Constipation: 2 people, 6.67%
General Anaesthesia: 2 people, 6.67%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 6.67%
Neuralgia (pain in one or more nerves): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Ketamine hcl and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ketamine hcl:

Ketamine hcl (1,851 reports)

Weakness treatments and more:

Weakness (586,877 reports)

Browse all side effects of Ketamine hcl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,638 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,618 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ketamine hydrochloride (the active ingredients of Ketamine hcl) and Ketamine hcl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.